Type 1 diabetes patients in England and Wales face inequitable access to technologies such as continuous glucose monitoring which is leaving less than one third at HbA1c targets, warn experts.
Medscape News UK
Original Article: Lack of Access to Type 1 Diabetes Technology 'Unacceptable'